Phenomenex is a global leader in developing innovative analytical chemistry solutions, dedicated to addressing the separation and purification challenges faced by researchers in industrial, government, and academic laboratories. The company's chromatography solutions play a pivotal role in a range of critical applications, from drug discovery and pharmaceutical development to disease diagnosis, food safety, and environmental analysis, accelerating scientific progress and contributing to global health improvement. Phenomenex's position within Danaher, renowned for its science and technology leadership, propels its solutions to the forefront of the industry, enabling wider accessibility. As part of Danaher, Phenomenex is able to offer unparalleled expertise and solutions to its customers, leveraging the collective strength of Danaher's businesses across biotechnology, diagnostics, and life sciences. Founded in 1982, Phenomenex continues to make strides in the biotechnology sector, embodying its slogan of "Enabling scientists inside the lab to create a better world outside." For more insights and updates, visit Phenomenex.blog.
There is no investment information
No recent news or press coverage available for Phenomenex.